Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | T5D73 | IM / LA |
Patient received the Hep B vaccine in the Left Deltoid on 02/19/2025 at 0846 am. Tinnitus-like symptoms started on 02/19/25 at 1530 pm in both ears. Patient self-medicated with ibuprofen the evening of 02/19/25 but experienced little relief. Patient woke up 02/20/25 to worsened symptoms and experienced amplified sensitivity to sound and wind, and heard vibrations when she spoke. Patient experienced difficulty hearing bilaterally, but diminished hearing was worse in the left ear than the right. Patient was seen in the ED on 02/20/25 around 0800 am for worsening symptoms. CT of the head and neck with and without contrast were performed while in the ED. CT results were normal. EKG and blood work were also done. A referral to otolaryngology was made for the patient. Patient is also following up with a location to have an audiology test performed as of today, 02/21/25.
none known
hypertension; potential hyperlipidemia
none known
sulfa drugs, flexeril, nitrofurantoin macrocrystal, cyclobenzaprine, nitrofurantoin monohyd/m-cryst, macrodantin
CT of the head and neck with and without contrast performed 02/20/25. CT scans were normal. EKG completed 02/20/25 and indicated sinus bradycardia. CBC with auto diff and BMP drawn 02/20/25. Magnesium level was1.8 on 02/20/25.